Mangoceuticals, Inc. (MGRX) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 |
|---|
| Sales/Revenue | 67.86K | 94.36K | 84.25K | 168.11K | 109.31K | 105.25K | 133.37K | 163.16K | 214.09K | 244.37K | 245.16K | 141.24K | 100.72K | 8.94K | 0 | 0 | 0 |
| Revenue Growth % | -37.91% | -10.34% | -36.83% | 3.03% | -48.95% | -56.93% | -45.6% | 15.52% | 112.56% | 2633.8% | - | - | - | - | - | - | - |
| Cost of Goods Sold | 38.86K | 46.88K | 33.35K | 78.16K | 47.24K | 25.14K | 50.7K | 93.37K | 66.7K | 101.79K | 100.57K | 54.11K | 43.52K | 4.09K | 0 | 0 | 0 |
| COGS % of Revenue | 57.27% | 49.69% | 39.58% | 46.49% | 43.22% | 23.89% | 38.01% | 57.23% | 31.15% | 41.65% | 41.02% | 38.31% | 43.21% | 45.73% | - | - | - |
| Gross Profit | 29K | 47.48K | 50.9K | 89.95K | 62.06K | 80.1K | 82.67K | 69.79K | 147.4K | 142.58K | 144.59K | 87.13K | 57.2K | 4.85K | 0 | 0 | 0 |
| Gross Margin % | 42.73% | 50.31% | 60.42% | 53.51% | 56.78% | 76.11% | 61.99% | 42.77% | 68.85% | 58.35% | 58.98% | 61.69% | 56.79% | 54.26% | - | - | - |
| Gross Profit Growth % | -53.27% | -40.73% | -38.43% | 28.88% | -57.89% | -43.82% | -42.82% | -19.9% | 157.69% | 2839.86% | - | - | - | - | - | - | - |
| Operating Expenses | 3.16M | 1.54M | 7.59M | 5.36M | 4.92M | 1.76M | 1.84M | 2.24M | 2.52M | 2.71M | 1.94M | 2.38M | 2.62M | 676.71K | 991.83K | 327.9K | 18.71K |
| OpEx % of Revenue | 4649.49% | 1629.77% | 9013.87% | 3187.48% | 4496.78% | 1670.36% | 1380.39% | 1371.9% | 1174.72% | 1109.21% | 792.95% | 1684.68% | 2597.57% | 7570.25% | - | - | - |
| Selling, General & Admin | 1.15M | -4.59M | 416.29K | 5.25M | 3.5M | 1.74M | 1.59M | 2.2M | 1.62M | 1.29M | 1.69M | 2.29M | 1.45M | 676.71K | 909.4K | 327.9K | 18.71K |
| SG&A % of Revenue | 1691.91% | -4859.85% | 494.14% | 3124.43% | 3198.59% | 1655.17% | 1189% | 1347.38% | 758.7% | 526.58% | 688.75% | 1620.6% | 1441.95% | 7570.25% | - | - | - |
| Research & Development | 0 | 0 | 0 | 0 | 0 | 171.86K | 188.78K | 0 | 0 | 361.74K | 0 | 0 | 131.42K | 0 | 31.42K | 0 | 0 |
| R&D % of Revenue | - | - | - | - | - | 163.29% | 141.55% | - | - | 148.03% | - | - | 130.48% | - | - | - | - |
| Other Operating Expenses | 1000K | 1000K | 1000K | 106K | 1000K | -155.88K | 66.47K | 40K | 890.67K | 1000K | 255.5K | 90.5K | 1000K | 0 | 51K | 0 | 0 |
| Operating Income | -3.13M | -1.49M | -7.54M | -5.27M | -4.85M | -1.68M | -1.76M | -2.17M | -2.37M | -2.57M | -1.8M | -2.29M | -2.56M | -671.86K | -991.83K | -327.9K | -18.71K |
| Operating Margin % | -4606.75% | -1579.46% | -8953.45% | -3133.98% | -4440% | -1594.34% | -1318.16% | -1329.13% | -1105.87% | -1050.87% | -733.81% | -1622.99% | -2540.78% | -7516% | - | - | - |
| Operating Income Growth % | 35.58% | 11.18% | -329.06% | -142.94% | -104.98% | 34.66% | 2.28% | 5.39% | 7.48% | -282.23% | -81.38% | -599.07% | -13577.85% | - | - | - | - |
| EBITDA | -2.85M | -1.04M | -7.52M | -4.43M | -4.44M | -956.21K | -1.76M | -2.14M | -2.36M | -2.56M | -1.79M | -2.29M | -2.55M | -667.99K | 0 | -327.9K | -18.71K |
| EBITDA Margin % | -4198.86% | -1104.52% | -8923.98% | -2636.54% | -4060.34% | -908.54% | -1317.97% | -1309.23% | -1102.96% | -1048.29% | -731.24% | -1618.58% | -2534.74% | -7472.78% | - | - | - |
| EBITDA Growth % | 35.8% | -9% | -327.71% | -107.48% | -87.95% | 62.67% | 1.95% | 6.55% | 7.51% | -283.5% | - | -597.17% | -13545.34% | - | - | - | - |
| D&A (Non-Cash Add-back) | 276.81K | 448.15K | 24.83K | 836.23K | 414.99K | 721.79K | 252 | 32.46K | 6.22K | 6.29K | 6.29K | 6.22K | 6.08K | 3.86K | 991.83K | 0 | 0 |
| EBIT | -3.4M | -2.75M | -7.54M | -5.39M | -4.85M | -2.4M | -1.76M | -2.17M | -2.22M | -2.24M | -1.8M | -2.28M | -1.93M | -671.86K | -991.83K | -327.9K | -18.71K |
| Net Interest Income | -276.81K | -19.66K | -75.85K | -21.7K | 13.7K | 450.6K | -242K | -223K | 0 | -6.47K | 0 | 8.23K | -1.76K | -1.8K | -3.09K | -1.58K | -889 |
| Interest Income | 0 | 0 | 0 | 0 | 13.7K | 0 | 0 | 0 | 0 | 0 | 0 | 8.23K | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 276.81K | 19.66K | 75.85K | 21.7K | 0 | -450.6K | 241.62K | 222.68K | 0 | 6.47K | 0 | 0 | 1.76K | 1.8K | 3.09K | 1.58K | 889 |
| Other Income/Expense | -276.81K | -1.28M | -75.85K | -147.32K | 13.7K | -271K | -242K | -222.68K | 0 | 0 | 0 | 8.23K | -1.76K | -1.8K | -3.09K | -1.58K | -889 |
| Pretax Income | -3.4M | -2.77M | -7.62M | -5.42M | -4.84M | -1.95M | -2M | -2.39M | -2.37M | -2.57M | -1.8M | -2.28M | -2.56M | -673.65K | -994.91K | -329.49K | -19.6K |
| Pretax Margin % | -5014.65% | -2934.9% | -9043.49% | -3221.61% | -4427.47% | -1851.83% | -1499.61% | -1465.6% | -1105.87% | -1050.87% | -733.81% | -1617.16% | -2542.53% | -7536.13% | - | - | - |
| Income Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.4M | -2.77M | -7.62M | -5.42M | -4.84M | -1.95M | -2M | -2.39M | -2.37M | -2.57M | -1.8M | -2.28M | -2.56M | -673.65K | -994.91K | -329.49K | -19.6K |
| Net Margin % | -5014.65% | -2935.6% | -9042.82% | -3221.61% | -4427.38% | -1850.88% | -1498.86% | -1465.39% | -1105.86% | -1050.87% | -733.81% | -1617.16% | -2542.53% | -7536.13% | - | - | - |
| Net Income Growth % | 29.68% | -42.2% | -281.1% | -126.51% | -104.4% | 24.14% | -11.12% | -4.68% | 7.55% | -281.21% | -80.82% | -593.21% | -12966.41% | - | - | - | - |
| Net Income (Continuing) | -3.4M | -2.77M | -7.62M | -5.42M | -4.84M | -1.95M | -2M | -2.39M | -2.37M | -2.57M | -1.8M | -2.28M | -2.56M | -673.65K | -994.91K | -329.49K | -19.6K |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | -1.53K | -1.54K | -1.74K | -1.18K | -1.18K | -1.08K | -837 | -376 | -36 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.34 | -0.19 | -0.69 | -0.54 | -1.05 | -0.60 | -0.99 | -1.37 | -1.50 | -1.98 | -1.70 | -2.05 | -3.41 | -0.75 | -1.00 | -0.33 | -0.02 |
| EPS Growth % | 67.73% | 68.35% | 30.49% | 60.7% | 29.76% | 69.68% | 41.61% | 32.96% | 56.04% | -164% | -70% | -521.15% | -17307.65% | - | - | - | - |
| EPS (Basic) | -0.34 | -0.19 | -0.69 | -0.54 | -1.05 | -0.60 | -0.99 | -1.37 | -1.56 | -1.98 | -1.70 | -2.05 | -3.41 | -0.75 | -1.00 | -0.33 | -0.02 |
| Diluted Shares Outstanding | 10.07M | 10.07M | 11.52M | 9.98M | 4.59M | 3.25M | 2.01M | 1.74M | 1.52M | 1.3M | 1.06M | 1.11M | 750.56K | 896.81K | 997.67K | 997.67K | 997.67K |
| Basic Shares Outstanding | 10.07M | 10.07M | 11.52M | 9.98M | 4.59M | 3.25M | 2.01M | 1.74M | 1.52M | 1.3M | 1.06M | 1.11M | 750.56K | 896.81K | 997.67K | 997.67K | 997.67K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |